BB Biotech AG Logo

BB Biotech AG

ISIN

CH0038389992

Ticker

BION

Sector

Health Care

Sub-Industry

Biotechnology

Country

Switzerland

Year Founded

1993

About BB Biotech AG

Company Description

Since our foundation in 1993, we have offered investors direct access to a select portfolio of promising, fast growing and profitable biotech companies listed on stock markets around the world. Thanks to our strong track record over the years and our systematic strategy and clear focus, we have become one of the world’s largest biotech investors.

Biotechnology is one of the most attractive of any sector today with estimated annual growth in the double-digits. Mega trends such as increasing life expectancy and a westernized diet and lifestyle are powerful growth drivers. These mega trends have led to a tremendous increase in healthcare costs, which, in turn, only amplifies the need for more efficient and effective drugs.

Served Area

Worldwide

Headquarters

Schwertstrasse 6
8200, Schaffhausen
Switzerland

Financial statements

Download as Excel
Line item in (chf) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Cash and cash equivalents 30,707,000.00 6,816,000.00 2,835,000.00 1,948,000.00
Other Current Liabilities N/A 5,709,000.00 5,431,000.00 4,143,000.00
Line item in (chf) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue From Dividends 243,000.00 0.00 N/A
Profit (loss) 691,174,000.00 -404,808,000.00 -357,812,000.00
Line item in (chf) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A 691,174,000.00 -404,808,000.00 -357,812,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes N/A -23,891,000.00 -3,981,000.00 -887,000.00
Cash and cash equivalents 30,707,000.00 6,816,000.00 2,835,000.00 1,948,000.00

Please note that some sums might not add up.

Filings & Publications

  • Consolidated Report 2022 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2022 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2022 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2022 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2022 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2021 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2021 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2021 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2021 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2021 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2021 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2021 - Q4 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2020 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2020 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2020 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2020 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q4 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q4 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2018 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q4 German πŸ‡©πŸ‡ͺ

Insider Trades

Date Trading entity / Person Association Trade type Volume
30.04.2024 None Non-Executive member Buy CHF 41,450.00
25.03.2024 None Non-Executive member Buy CHF 55,167.50
22.03.2024 None Non-Executive member Buy CHF 105,927.16

Capital Markets Information

ISIN

CH0038389992

LEI

391200MBZQNPFHIVKO34

Sub-Industry

Biotechnology

Listed Stock Exchange

SIX Swiss Exchange

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.